N
LIVE

Serial Number

79350434

Owner

Financière N

Attorney

Andy I. Corea

Filing Date

Apr 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

N Trademark

Serial Number: 79350434 • Registration: 7772505

N is a trademark filed by Financière N on April 28, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 21 (Housewares). The application is currently registered and active.

Owner Contact Info

Financière N (4 trademarks)

Immeuble Eklaa,

Entity Type: 03

Trademark Details

Filing Date

April 28, 2022

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Dispensers made of plastic materials, namely, spray bottles for home use sold empty; dispensing pumps for attachment to aerosols and other containers of plastic, namely, manually actuated pump dispensers for attachment to containers for dispensing liquids, paste or powders for home use; plastic spray nozzles of plastic for use with pumps for dispensing liquid, powder or paste products; containers of plastic, for domestic use, for use in the storage of pharmaceutical and medical preparations, and plastic caps adapted therefor; empty spray bottles, bottles sold empty; all the aforesaid goods exclusively relating to packaging, packing and systems for dosing and dispensing, in the field of health, particularly for pharmaceutical, parapharmaceutical, medical and veterinary preparations

Technical research in the field of packaging, packages and pump systems used for dosing and dispensing medical, pharmaceutical and parapharmaceutical products; technical project planning and design of research studies, namely, conducting of feasibility studies in the field of packaging, packages and devices used for dosing or dispensing medical, pharmaceutical and parapharmaceutical products; industrial research services; quality control for third parties; pharmaceutical research services; industrial design services; graphic arts design services; design and development of electronic hardware and software related to medical and medicinal devices, instruments and tools, in particular add-ons or drug delivery devices, especially inhalers, sprayers, droppers and injection devices; research and development services for new products for third parties; technical consulting in relation to the aforesaid services; all the aforesaid services exclusively relating to packaging, analysis, plastics processing, and drug delivery systems, including medical apparatus, devices, instruments and tools, for drug dispensing and delivery especially injection molds and assembly machines for use in assembly, in the field of health, particularly for pharmaceutical, parapharmaceutical, medical and veterinary preparations

Medical apparatus namely, drug delivery devices sold empty, in the nature of medical syringes, infusion sets, pump activated sprayers for dispensing medicine, atomizers for dispensing medicine, droppers for dispensing medicine, dosage dispensers for administering medicine to patients, medical fluid injectors, vaporizers for administering medicine, and inhalers; surgical instruments for medical use; protective equipment for surgical and medical apparatus and instruments, namely, protective cases fitted for surgical and medical instruments; cases specially adapted for the transport, storage and protection of devices for administering drugs, namely, cases specially adapted for drug delivery devices sold empty in the nature of syringes, infusion sets, pump activated sprayers for dispensing medicine, atomizers for dispensing medicine, droppers for dispensing medicine, dosage dispensers for administering medicine to patients, medical fluid injectors, vaporizers for administering medicine, and inhalers; apparatus for dosing and administering medical products for humans and animals, namely, inhalers for medical purposes sold empty, sprayers being atomizers sold empty for medical use, droppers for administering medication sold empty, dosage dispensers for administering medicine to patients, medical fluid injectors for administering medicine to patients, dermal distributers being applicators for delivering topical medications directly to skin in the nature of manually actuated push-button dispensers and injection devices being pen injectors, implant injectors and autoinjectors sold empty, and cases specially adapted therefor; dispensing apparatus for use in dispensing medical products for humans and animals, namely, aerosols dispensers being inhalers for medical purposes sold empty, vaporizers for medical use, droppers for administering medication sold empty, inhalers for medical purposes sold empty, and medical fluid injectors being pen injectors, implant injector and autoinjectors sold empty; security devices for use for protecting users of medical devices, namely, safety fitted covers and caps specially adapted for use with and sold as an integral component of drug delivery syringes and infusion sets sold empty, atomizers for medical use sold empty, droppers for administering medication sold empty, and dosage dispensers for administering medicine to patients; devices to be attached to containers for dispensing the contents of these containers, for medical use in humans or animals, namely, dosage dispensers for administering medicine to patients; closures for use in apparatus for dispensing, dosing and/or administering medical products used in humans or animals, namely, fitted covers specially adapted for dosage dispensers for administering medicine to humans and animal patients; pressurized dispensers for medical use being dosage dispensers for administering medicine to patients; packaging containers for the supply of medicines and pharmaceuticals being dispensers and applicators for administering medicine to patients, in the nature of pen injectors, implant injectors and autoinjectors sold empty, atomizers and vaporizers for medical use sold empty, droppers for administering medication sold empty, and dosage dispensers for administering medicine to patients; medicine injectors for administering medication sold empty, medical syringes sold empty, droppers for administering medication sold empty, injection pens sold without medication, infusion pumps for administering medicines, transdermal drug delivery patch sold without medication, portable injectors being medical fluid injectors for administering medication sold empty, patch pumps being medical infusion pumps, metering pumps being drug delivery pumps and vaporizers for medical use; apparatus for dosing and administering medical products for humans and animals, namely, inhalers sold empty, vaporizers, droppers sold empty, and injection devices being pen injectors, implant injectors and autoinjectors sold empty

Custom manufacture of apparatus for dosing, delivering or administering medical products for humans or animals, namely, inhalers, vaporizers, droppers and injection devices; custom manufacture of drug delivery devices and parts thereof for use in administering and dispensing medical products to humans or animals

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 18, 2025 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
GENERIC MADRID TRANSACTION SENT TO IB
Nov 14, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 13, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 29, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 13, 2025 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Oct 1, 2024 GNS1
SUBSEQUENT FINAL EMAILED
Oct 1, 2024 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Oct 1, 2024 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 2, 2024 RFNP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 18, 2024 OPNX
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 29, 2024 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 28, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 28, 2024 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 23, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 16, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 16, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 16, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2023 TROA
REFUSAL PROCESSED BY IB
May 2, 2023 RFNT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 16, 2023 ADCH
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 11, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 11, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 22, 2023 RFCR
NON-FINAL ACTION WRITTEN
Feb 21, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 27, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 22, 2022 REPR